Dormant Company Accounts - BIONET RESEARCH LIMITED

Dormant Company Accounts - BIONET RESEARCH LIMITED

BIONET RESEARCH LIMITED - Company Information

Print Friendly Version

true 2017-01-01 2017-12-31 false 02238207 uk-bus:Director1 2017-01-01 2017-12-31 02238207 uk-bus:Director2 2017-01-01 2017-12-31 02238207 2017-01-01 2017-12-31 02238207 2017-12-31 02238207 uk-bus:EntityHasNeverTraded 2017-01-01 2017-12-31 02238207 uk-bus:FRS102 2017-01-01 2017-12-31 02238207 uk-bus:FullAccounts 2017-01-01 2017-12-31 02238207 uk-bus:AuditExempt-NoAccountantsReport 2017-01-01 2017-12-31 02238207 2016-12-31 02238207 uk-bus:OrdinaryShareClass1 2017-01-01 2017-12-31 02238207 uk-bus:OrdinaryShareClass2 2017-01-01 2017-12-31 02238207 uk-bus:OrdinaryShareClass3 2017-01-01 2017-12-31 02238207 uk-bus:PreferenceShareClass1 2017-01-01 2017-12-31 02238207 uk-bus:PreferenceShareClass2 2017-01-01 2017-12-31 02238207 uk-bus:PreferenceShareClass3 2017-01-01 2017-12-31 02238207 uk-core:ShareCapitalPreferenceShares 2017-12-31 02238207 uk-core:ShareCapitalPreferenceShares 2016-12-31 iso4217:GBP xbrli:shares

Registered Number 02238207

BIONET RESEARCH LIMITED

Dormant Accounts

31 December 2017

BIONET RESEARCH LIMITED Registered Number 02238207

Balance Sheet as at 31 December 2017

2017 2016
£ £
Called up share capital not paid
200
200
Net assets
200
200
Issued share capital
200 Ordinary Shares of £ 1 each 200 200
Total Shareholder funds
200
200

STATEMENTS

  1. For the year ending 31 December 2017 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 March 2018

And signed on their behalf by:
Dr Joseph Carey, Director